NGVT
Get informed when a big investor buys or sells
+ FollowOvervalued by 78.8% based on the discounted cash flow analysis.
| Market cap | $2.55 Billion |
|---|---|
| Enterprise Value | $3.66 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.61 |
| Beta | 1.19 |
| Outstanding Shares | 35,300,000 |
| P/E Ratio | -20.28 |
|---|---|
| PEG | -10.58 |
| Price to Sales | 2.14 |
| Price to Book Ratio | 72.66 |
| Enterprise Value to Revenue | 3.02 |
| Enterprise Value to EBIT | -35.11 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 30.96 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1871▼ 1.68% |
|---|---|
| Total Calls | 17,100▼ 14.93% |
| Total Puts | 3,200▼ 21.95% |
Holdings and activity of institutional investors.
| Ownership % | 100.64%▼ 1.97% |
|---|---|
| Total Invested | $2.56B▲ 16.07% |
| Investors Holding | 306▲ 3.00% |
No data
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...